JP2021520367A5 - - Google Patents

Info

Publication number
JP2021520367A5
JP2021520367A5 JP2020554193A JP2020554193A JP2021520367A5 JP 2021520367 A5 JP2021520367 A5 JP 2021520367A5 JP 2020554193 A JP2020554193 A JP 2020554193A JP 2020554193 A JP2020554193 A JP 2020554193A JP 2021520367 A5 JP2021520367 A5 JP 2021520367A5
Authority
JP
Japan
Prior art keywords
approximately
suspension
suspension according
amlodipine
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020554193A
Other languages
English (en)
Japanese (ja)
Other versions
JP7456933B2 (ja
JP2021520367A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/027044 external-priority patent/WO2019200143A1/en
Publication of JP2021520367A publication Critical patent/JP2021520367A/ja
Publication of JP2021520367A5 publication Critical patent/JP2021520367A5/ja
Application granted granted Critical
Publication of JP7456933B2 publication Critical patent/JP7456933B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020554193A 2018-04-11 2019-04-11 アムロジピン製剤 Active JP7456933B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656188P 2018-04-11 2018-04-11
US62/656,188 2018-04-11
PCT/US2019/027044 WO2019200143A1 (en) 2018-04-11 2019-04-11 Amlodipine formulations

Publications (3)

Publication Number Publication Date
JP2021520367A JP2021520367A (ja) 2021-08-19
JP2021520367A5 true JP2021520367A5 (https=) 2024-02-07
JP7456933B2 JP7456933B2 (ja) 2024-03-27

Family

ID=68161047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554193A Active JP7456933B2 (ja) 2018-04-11 2019-04-11 アムロジピン製剤

Country Status (6)

Country Link
US (6) US10799453B2 (https=)
EP (1) EP3773574A4 (https=)
JP (1) JP7456933B2 (https=)
CN (1) CN112334134A (https=)
CA (1) CA3096101A1 (https=)
WO (1) WO2019200143A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3960158B1 (en) 2016-10-07 2025-05-21 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
WO2019200143A1 (en) 2018-04-11 2019-10-17 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CN112716903B (zh) * 2021-01-18 2023-03-21 广州一品红制药有限公司 一种氨氯地平干混悬剂及其制备方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US6057344A (en) 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
US6333342B1 (en) 1998-11-04 2001-12-25 Isotechnika, Inc Methods of pharmacological treatment using S(−) amlodipine
CN1100038C (zh) 2000-02-21 2003-01-29 张喜田 氨氯地平对映体的拆分
PL362660A1 (en) 2000-12-29 2004-11-02 Pfizer Limited Process for making amlodipine maleate
WO2002053540A1 (en) 2000-12-29 2002-07-11 Pfizer Limited Aspartate derivative of amlodipine as calcium channel antagonist
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1309557B9 (en) 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309556B1 (en) 2000-12-29 2004-11-24 Pfizer Limited Amlodipine fumarate
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
CA2433193C (en) 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
IL161448A0 (en) 2001-10-24 2004-09-27 Sepracor Inc Method of resolving amlodipine racemate
KR100496436B1 (ko) 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
AU2003253460A1 (en) 2002-09-19 2004-04-08 Cj Corporation Crystalline organic acid salt of amlodipine
CA2559670A1 (en) 2003-04-14 2004-10-28 Gabor Pragai Stable amlodipine maleate formulations
WO2005079772A2 (en) 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
US20060030602A1 (en) * 2004-03-16 2006-02-09 Sepracor Inc. (S)-amlodipine malate
WO2005099699A1 (en) 2004-04-07 2005-10-27 Sepracor Inc. Combination of (s)-amlodipine and a beta-blocker, and methods for reducing hypertension
WO2006059217A1 (en) 2004-12-01 2006-06-08 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine besylate and processes for their preparation
EP1831166B1 (en) 2004-12-02 2010-10-20 SK Chemicals, Co., Ltd. Optical resolution method of amlodipine
GT200600371A (es) 2005-08-17 2007-03-21 Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
CN101522174A (zh) 2006-05-10 2009-09-02 赢创德固赛有限责任公司 辊压热解制备的二氧化硅在药物组合物中的应用
CA2655596C (en) * 2006-06-27 2011-10-25 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
DK2200588T3 (da) 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
CN101416966B (zh) 2007-10-22 2010-11-10 鲁南制药集团股份有限公司 一种治疗高血压的药物组合物
KR20100052262A (ko) 2008-11-10 2010-05-19 (주)아모레퍼시픽 난용성 약물의 나노입자를 포함하는 분말의 제조방법, 그에의해 제조된 분말 및 이를 포함하는 약학적 조성물
CN102256604A (zh) * 2008-12-17 2011-11-23 株式会社医药处方 稳定的氨氯地平含水口服制剂
CN101843615A (zh) 2010-06-25 2010-09-29 包丽昕 含有缬沙坦和苯磺酸氨氯地平的分散片及其制备方法
CN102370965A (zh) 2010-08-11 2012-03-14 南京先宇科技有限公司 一种含有左旋氨氯地平药学上可接受的盐与培哚普利药学上可接受的盐的药物组合物
CN102018708A (zh) 2010-12-12 2011-04-20 林飞 包含氨氯地平和阿托伐他汀镁的药物组合物
CN102114017A (zh) 2011-01-05 2011-07-06 王定豪 包含氨氯地平和培哚普利的药物组合物及其应用
CN102746215A (zh) * 2011-04-18 2012-10-24 张兆勇 一种制备高纯度盐酸贝尼地平的方法
WO2013191668A1 (en) * 2012-06-22 2013-12-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions preventing hypertension comprising soluplus
US20140024723A1 (en) 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a specific hydroxypropyl methylcellulose
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
EP3960158B1 (en) 2016-10-07 2025-05-21 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
WO2019200143A1 (en) 2018-04-11 2019-10-17 Silvergate Pharmaceuticals, Inc. Amlodipine formulations

Similar Documents

Publication Publication Date Title
JP2021520367A5 (https=)
RU2700700C2 (ru) Композиции для ухода за полостью рта и способы их применения
CN104023796B (zh) 口腔护理组合物
JP2020007356A5 (https=)
CN108024917A (zh) 口腔护理组合物及使用方法
CN108024925A (zh) 口腔护理组合物
US12558330B2 (en) Methods and compositions for treating edema refractory to oral diuretics
CN108024916A (zh) 口腔护理组合物及使用方法
AU2020304368B2 (en) Oral care compositions and methods of use
JP2013540151A5 (https=)
WO2009084041A4 (en) Pharmaceutical compositions of dexibuprofen
AU2022287601B2 (en) Oral care composition comprising zinc and an amino acid for treating symptoms of a gastric disorder in the oral cavity
JP2006525345A5 (https=)
JP2019502735A (ja) 局所用薬剤を含むガレヌス製剤
PL214226B1 (pl) Preparat zawierajacy podstawione pochodne imidazolu
JP7102147B2 (ja) 放射線療法に起因する皮膚損傷の予防における使用のための、クロニジンおよび/またはクロニジン誘導体
JP2026071267A (ja) ラパマイシン組成物
WO2015046281A1 (ja) 安定化された2-アミノ-3-(4-ブロモベンゾイル)フェニル酢酸含有水性組成物
RU2022119027A (ru) Фармацевтическая композиция трициклического соединения двойного ингибитора фдэ3/фдэ4
JP2006298907A (ja) 点眼剤